This program will focus on the diagnosis and treatment of narcolepsy and EDS in OSA. Format will consist of state-of-the-art lectures and debates chaired by Michael Thorpy, MD with faculty Michael Sateia, MD; Thomas Scammell, MD,Kingman Strohl, MD; Phyllis Zee, MD, PhD
Obstructive sleep apnea (OSA) and narcolepsy are sleep disorders associated with high prevalence and
symptomatic burden including prominent sleepiness, daytime dysfunction, and poor nocturnal sleep. Both OSA
and narcolepsy have an elevated risk of adverse health outcomes. Diagnosis of narcolepsy is often challenging and
encompasses clinical, electrophysiological, and biological evaluations. The causes of excessive daytime sleepiness
(EDS) in OSA may not all be related to the OSA, and EDS may remain even with high use of CPAP. Current therapies
for adults with narcolepsy are often underutilized, and agents using novel mechanisms to treat targeted symptoms
such as EDS in OSA and narcolepsy are in development. This program will focus on the diagnosis and treatment of
narcolepsy and EDS in OSA. Format will consist of state-of-the-art lectures and debates.
or